Showing results (211-220 of 462) with videos related to

Sort By:
Pageof 47
Central Nervous System Agents in Medicinal Chemistry|September 4, 2026
Effect of Green-Synthesized Curcumin-Coated Silver Nanoparticles on the Hippocampal Tissue in Chlorpyrifos-Exposed Developing Male RatsAmirhossein Rakhshanifard, Saeed Samarghandian, Mehdi Shakibaie, et al.
Central Nervous System Agents in Medicinal Chemistry|October 22, 2020
Old Drugs with New Tricks: Paradigm in Drug Development Pipeline for Alzheimer's DiseaseTanay Dalvi, Bhaskar Dewangan, Rudradip Das, et al.
Central Nervous System Agents in Medicinal Chemistry|June 17, 2022
Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative DisordersAala Azari, Amin Goodarzi, Behrouz Jafarkhani, et al.
Central Nervous System Agents in Medicinal Chemistry|June 24, 2021
Anti-convulsive Effect of Thiamine and Melatonin Combination in Mice: Involvement of Oxidative StressEhsan Dehdashtian, Azam Hosseinzadeh, Karim Hemati, et al.
Central Nervous System Agents in Medicinal Chemistry|June 8, 2022
Phyllanthus emblica L. Regulates BDNF/PI3K Pathway to Modulate Glutathione for Mitoprotection and Neuroprotection in a Rodent Model of Ischemic StrokeDeepaneeta Sarmah, Geetesh Verma, Aishika Datta, et al.
Central Nervous System Agents in Medicinal Chemistry|June 24, 2022
Formulation, Development, and in-vitro Evaluation of Escitalopram Fast Dissolving TabletsVishal Bhatia, Ashwani K Dhingra, Rameshwar Dass, et al.
Central Nervous System Agents in Medicinal Chemistry|April 18, 2022
Is there Cholinesterase Activity in the Eye?Sandra Carolina Durán-Cristiano
Central Nervous System Agents in Medicinal Chemistry|September 28, 2010
Biomarkers of cell damage induced by oxidative stress in Parkinson's disease and related modelsJulio César Tobón-Velasco, Liliana Carmona-Aparicio, Syed F Ali, et al.
Central Nervous System Agents in Medicinal Chemistry|January 22, 2011
Neurogenic drugs and compounds to treat CNS diseases and disordersPhilippe Taupin
Central Nervous System Agents in Medicinal Chemistry|September 4, 2010
Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseasesF H Ebner, S Mariotto, E Darra, et al.
Pageof 47